Table of Contents Table of Contents
Previous Page  202 / 290 Next Page
Information
Show Menu
Previous Page 202 / 290 Next Page
Page Background

P-632

Social and community networks in obese elderly

A.C.C. Freitas

1

, L.R. Lima

1

, S.S. Funghetto

1

, C.R.G. Volpe

1

, W.S. Santos

1

, T.

C.M.S.B. Rehem

1

, A.O. Silva

2

, M.M. Stival

2

.

1

Nursing Course, College of

Ceilandia, University of Brasilia,

2

Physical Education Course, Center of

University UniCeub, Brazil

Introduction:

social and community networks are forms from social

ties made by relatives, neighbors, friends and when established in the

life of the elderly working in health promotion, disease protection and

even increased survival. This study aimed to evaluate the social and

community networks of obese elderly in Brasilia, Brazil.

Methods:

Cross-sectional study with 206 obese elderly classified by

anthropometry and bioimpedance. Household Survey was applied to

investigate the social and community networks of the elderly using

the Family APGAR. Data were analyzed by SPSS 20.0. Research

approved by the Ethics Committee of SES Research 451/10.

Results:

The mean BMI was 31.36 and body fat percentage of 40.79%.

Most were female, with 1

4 years of study, married, low income, were

not diet, not smoking, not using alcohol, sedentary and had no leisure.

82.0% Family APGAR pointed out the family as highly functional, 42.7%

did not offer help, 84.0% lived with children, 82.5% were not

community support, 76.7% provided no voluntary service in the

community, 76.7% livewith people of the same age and 92.2% livewith

young people. Factorial Analysis of Family APGAR: Bartlett: x² = 1024.0

and p < 0.000; KMO 0.896. After extraction of the factors, the values

remained less than one, with explained variance of accumulation of

82.4%, demonstrating unifactorial instrument.

Conclusion:

It is very important the role of Social and Community

Networks in elderly life as regards their health and quality of life.

P-633

Integrated continuous glucose monitoring/insulin Pump System in

elderly: the impact on self-perception of health status and

glycemic control

M.G. Borda

1,2

, E.A. Morros

1,2

, D. Patino-Hernandez

1,2

, M.

U. Pérez-Zepeda

3

, A.M. Gómez

4

, L. Marín

4

, D.A. Chavarro-Carvajal

1,2

,

C.A. Cano-Gutiérrez

1,2

.

1

Semillero de Neurociencias y Envejecimiento,

Instituto de Envejecimiento. Facultad de Medicina, Pontificia Universidad

Javeriana. Bogotá, Colombia,

2

Geriatrics Unit, Hospital Universitario San

Ignacio. Bogotá, Colombia,

3

Geriatric Epidemiology Research Department,

Instituto Nacional De Geriatría. Mexico City,

4

Endocrinology Unit,

Hospital Universitario San Ignacio. Bogotá, Colombia

Introduction:

The main purpose of the study was to evaluate the

effects of insulin pump therapy integrated with continuous glucose

monitoring (SAP) in metabolic control and self-rated perception of

health among older adults.

Methods:

Patients with type 1 and 2 Diabetes Mellitus with preserved

basic functionality, an adequate social support network and who had

been using SAP for at least a year were included for analysis. HbA1c was

measured prior to initiation of therapy with further monthly follow-

up. Recruitment took place from 2008 to 2014 with continuous

monitoring until October 2015 when measurements were taken again

and the self-rated health perception (SPH) was evaluated.

Results:

50 patients were included, 26 of which were younger than 60

years-of-age and 24were older. The average agewas 38 and 69.7 years-

of-age for younger and older adults respectively. Type 1 DM was

more prevalent in younger patients (84% vs.41.7%). In older adults after

SAP, the number of hospitalizations(12.85% vs.33%*), severe hypogly-

cemia (66.67% vs. 0%*) and HbA1c (9.06 ± 1.69 vs. 7.27 0.87*) decreased

and a significant improvement of SPH was found (46.08 ± 24.30 vs.

82.69 ± 18.86) (p < 0.05%*). No statistically significant differences were

found in terms of SRH (87.92 ± 12.98 vs. 82.69 ± 18.86*) or HbA1c

(p > 0.05*) comparing older and younger adults.

Conclusions:

Age should not be considered an exclusion criterion for

initiation of therapy with continuous glucose monitoring. This study

does not display significant differences between younger and older

adults, nevertheless, further investigation is required in order to aid

decision making in this field for geriatricians and endocrinologists.

P-634

Does Mini Nutritional Assessment predict disability among elderly

people?

D. Concu, A. Errigo, G.M. Pes.

University of Sassari

Introduction:

Nutritional status has been hypotesized to be a major

predictor of functional ability in elderly people. Assessment of nutri-

tional status in clinical practice is obtained by the Mini-Nutritional

Assessment (MNA) questionnaire. However, the reliability of MNA

for predicting functional decline and disability in older persons needs

further evidence. The aim of this study was to assess whether MNA

(30-items) in subjects aged 80 and over correlates with functional

status measured by the Activities of Daily Living (ADL) score.

Methods:

We recruited 562 Sardinian subjects (227 men, 335 women,

aged 80 and older). Age, ADL, Body Mass Index (BMI), MNA, Mini-

Mental State Examination (MMSE), Geriatric Depression Scale (GDS)

were collected in each participant. The association of predictors with

disability was performed by multiple linear regression analysis with

ADL as dependent variable.

Results:

Mean value of ADL score was 4.12 ± 2.0. Mean value of MNA

score was 18.9 ± 5.6. Multiple regression analysis gave the following

coefficients: Age (r =

0.127, p = 0.043) BMI (r =

0.250. p < 0.0001);

MNA (r = 0.352, p < 0.0001); MMSE (r = 0.299, p < 0.0001) and GDS

(r =

0.274, p < 0.0001).

Conclusions:

Nutrition is a key determinant of geriatric health, and

MNA is useful for nutritional assessment. Our analysis in subjects over

80 confirmed that MNA score is among the strongest predictors of

disability when compared to similar indicators. However, our data do

not allow to determine whether there is a real cause-effect releation-

ship between nutritional status and ADL, and which one is the primary

determinant.

P-635

Osteoporosis in Parkinson

s disease: a review

J. Correia

1

, T. Sequeira

2

, J. Caçoilo

1

, I. Calvinho

1

, C. Bento

1

, I. Venâncio

1

.

1

USF Oriente,

2

UCSP Marvila, Lisboa, Portugal

Introduction:

Parkinson

s disease (PD) and osteoporosis are chronic

diseases associated with aging. Several studies have reported

associations between these two entities, particularly regarding to

increased risk of fractures. The objectives of this work were to review

the existing evidence about the relationship between PD and

osteoporosis and to review the pathophysiological mechanisms

involved.

Methods:

Research guidelines, meta-analysis (MA), systematic

reviews (SR) and randomized controlled trials (RCT) in English

and Portuguese, in PubMed and medical databases based on

evidence. MeSH terms used:

Parkinson

s disease

and

osteoporosis

.

Articles published between January 2006 and January 2016 were

selected.

Results:

Four articles were obtained, but only three met the inclusion

criteria. One MA, one SR and one RCT showed a relation between PD

and osteoporosis, bone mineral density (BMD) and fracture risk.

Patients with PD have an increased risk for osteoporosis when

compared to the general population. It was also evident in PD: lower

BMD, lower vitamin D levels and an increased risk of fractures. The

reduction of bone mass in PD seems to be mainly caused by limited

mobility. Endocrine (such as vitamin D deficiency), nutritional and

iatrogenic factors also play an important role in the depletion of bone

mass.

Conclusions:

The available evidence supports an increased risk of

osteoporosis among PD patients. This fact should alert the clinician

about the importance of osteoporosis screening in PD patients.

However, more studies are needed in order to demonstrate the

health benefit of osteoporosis screening/early treatment in PD

patients.

Poster presentations / European Geriatric Medicine 7S1 (2016) S29

S259

S196